Tafluprost

Modify Date: 2024-01-02 22:29:05

Tafluprost Structure
Tafluprost structure
Common Name Tafluprost
CAS Number 209860-87-7 Molecular Weight 452.531
Density 1.2±0.1 g/cm3 Boiling Point 552.9±50.0 °C at 760 mmHg
Molecular Formula C25H34F2O5 Melting Point N/A
MSDS N/A Flash Point 288.2±30.1 °C

 Use of Tafluprost


Tafluprost(AFP-168) is an anti-glaucoma prostaglandin (PG) analog.Target:OthersTafluprost showed significant IOP-lowering effects without any safety concerns in patients with various types of glaucoma and OH in daily clinical practice and tafluprost is highly effective in any therapeutic patterns [1]. Tafluprost with reduced BAK has potential as a superior antiglaucoma drug, not only for its IOP-lowering effect, but also for its good corneal safety profile [2]. Tafluprost single-use vials treatment was effective in reducing IOP over the 3 years of this study, but visual field performance worsened by 10.3%-13.8% in patients with normal-tension glaucoma. Safety was satisfactory [3].

 Names

Name tafluprost
Synonym More Synonyms

 Tafluprost Biological Activity

Description Tafluprost(AFP-168) is an anti-glaucoma prostaglandin (PG) analog.Target:OthersTafluprost showed significant IOP-lowering effects without any safety concerns in patients with various types of glaucoma and OH in daily clinical practice and tafluprost is highly effective in any therapeutic patterns [1]. Tafluprost with reduced BAK has potential as a superior antiglaucoma drug, not only for its IOP-lowering effect, but also for its good corneal safety profile [2]. Tafluprost single-use vials treatment was effective in reducing IOP over the 3 years of this study, but visual field performance worsened by 10.3%-13.8% in patients with normal-tension glaucoma. Safety was satisfactory [3].
Related Catalog
References

[1]. Kuwayama, Y. and A. Nomura, Prospective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: short-term efficacy and safety. Adv Ther, 2014. 31(4): p. 461-71.

[2]. Kumagami, T., et al., Comparison of corneal safety and intraocular pressure-lowering effect of tafluprost ophthalmic solution with other prostaglandin ophthalmic solutions. J Ocul Pharmacol Ther, 2014. 30(4): p. 340-5.

[3]. Inoue, K., A. Tanaka, and G. Tomita, Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma. Clin Ophthalmol, 2013. 7: p. 1411-6.

 Chemical & Physical Properties

Density 1.2±0.1 g/cm3
Boiling Point 552.9±50.0 °C at 760 mmHg
Molecular Formula C25H34F2O5
Molecular Weight 452.531
Flash Point 288.2±30.1 °C
Exact Mass 452.237427
PSA 75.99000
LogP 4.23
Vapour Pressure 0.0±1.6 mmHg at 25°C
Index of Refraction 1.549
Storage condition -20℃

 Synonyms

Tapros
MK-2452
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5Z)-
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate
Saflutan
AFP-168
Isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-((1E)-3,3-difluoro-4-phenoxybut-1-enyl)-3,5-dihydroxycyclopentyl}hept-5-enoate
Taflotan
Tafluprost
Isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl}-5-heptenoate
UNII-1O6WQ6T7G3
Zioptan
Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: Tafluprost
  • Price: $450.0/100mg $850.0/250mg $1700.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao



Get all suppliers and price by the below link:

Tafluprost suppliers


Price: $99/10mM*1mLinDMSO

Reference only. check more Tafluprost price